Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Cancer Discovery
Balko, Justin M JM; Giltnane, Jennifer M JM; Wang, Kai K; Schwarz, Luis J LJ; Young, Christian D CD; Cook, Rebecca S RS; Owens, Phillip P; Sanders, Melinda E ME; Kuba, Maria G MG; Sánchez, Violeta V; Kurupi, Richard R; Moore, Preston D PD; Pinto, Joseph A JA; Doimi, Franco D FD; Gómez, Henry H; Horiuchi, Dai D; Goga, Andrei A; Lehmann, Brian D BD; Bauer, Joshua A JA; Pietenpol, Jennifer A JA; Ross, Jeffrey S JS; Palmer, Gary A GA; Yelensky, Roman R; Cronin, Maureen M; Miller, Vincent A VA; Stephens, Phillip J PJ; Arteaga, Carlos L CL